ESTRO 2025 - Abstract Book

S1453

Clinical - Lung

ESTRO 2025

Conclusion: Radiotherapy to primary thoracic disease showed beneficial 2-year survival outcome for patient with metastatic SCLC. Further investigations are necessary to validate this retrospective study outcome.

Keywords: SCLC, Radiotherapy, Primary thoracic tumor

References: 1. George J, Maas L, Abedpour N, et al. Evolutionary trajectories of small cell lung cancer under therapy. Nature . Mar 2024;627(8005):880-889. doi:10.1038/s41586-024-07177-7 2. Basler L, Kroeze SG, Guckenberger M. SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer . Apr 2017;106:50-57. doi:10.1016/j.lungcan.2017.02.007